In mice fed a high-fat diet, metformin reduced the activity of the STAT3-ERK-vimentin and fibronectin-integrin signaling pathways, with the outcome of blocking cancer cell vascular invasion and anaplasia and delaying tumor progression. This evidence concerns the gene STAT3 and neoplasm.